Pituitary & hypothalamus

Neurocognitive evaluation of patients with non-functioning pituitary adenoma

PituitaryPublished Case-control study

Authors' conclusion

Our findings suggest that the cognitive impairments observed in patients with NFPA may result not only from pituitary dysfunction but also from treatment approaches such as reoperations, gamma-knife or radiotherapy. These results highlight the importance of comprehensive neurocognitive assessment and long-term follow-up in the management of NFPA patients, particularly those with hormonal deficiencies or who undergo repeated interventions.

Study context

Population
Patients with non-functioning pituitary adenoma (NFPA) and matched controls; assessed with Beck Depression Inventory (BDI), Cognitive Failures Questionnaire (CFQ), Prospective and Retrospective Memory Questionnaire (PRMQ) and Memory Functioning Questionnaire (MFQ)matched controls
Participants
80 vs 80
Comparison
NFPA patients vs matched controls
  • NFPAn = 80
  • Controlsn = 80reference
Outcome
Neurocognitive functions (CFQ, PRMQ, MFQ; BDI for depression)
Methodological detailscontrols matched for age, sex, body mass index (BMI) and educational status
  • Controls matched for age, sex, BMI and educational status

Main finding

As reported in the abstract

  • NFPA had significantly higher CFQ and PRMQ scores than controls, reflecting greater cognitive failure and memory impairment
  • MFQ subscales: increased general forgetfulness, severity of forgetting and impaired retrospective function in NFPA (p < 0.05)
  • NFPA vs Controls: P < 0.05

Observational data: associations, not effects.

Further findings

Treatment and name recall (within NFPA)

Name recall declined as postoperative time increased
P = 0.029
Name recall worse after surgery or radiotherapy/gamma-knife

Social dysfunction (within NFPA)

More common with secondary adrenal insufficiency
P = 0.038
More common with higher corticosteroid doses
P < 0.05
More common with greater concentration problems
P = 0.036

Hypogonadism (within NFPA)

Associated with impaired name recall
P = 0.040
Associated with social failure
P = 0.024

Low IGF-1 (within NFPA)

Linked to worse prospective memory, more frequent forgetfulness and greater social dysfunction
P = 0.042

Original publication

Neurocognitive evaluation of patients with non-functioning pituitary adenoma. Pituitary. Published 26 September 2025. doi:10.1007/s11102-025-01582-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.